API Localization Programs
Various
Development/ProductionActive
Key Facts
About Pharmasyntez
Pharmasyntez is a major, vertically integrated Russian generics and API producer with a significant domestic manufacturing footprint. The company has established itself as a key player in addressing critical public health needs, particularly in anti-tuberculosis, HIV, and oncology therapeutics, through both in-house production and extensive R&D collaborations with Russian academic institutions. While primarily serving the Russian market, it expresses openness to international partnerships for technology transfer and co-development. Its strategy is aligned with national priorities for pharmaceutical import substitution and localization of production.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Generic Product Pipeline | Lannett | ANDA Development |
| Drug Repositioning Service | Biovista | Service |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |